| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 163 |
| 1 | METHOTREXATE SODIUM | 137 |
| 2 | METHOTREXATE | 134 |
| 3 | ADALIMUMAB | 82 |
| 4 | ETANERCEPT | 66 |
| 5 | PREDNISONE | 48 |
| 6 | PREDNISOLONE | 35 |
| 7 | PREDNISOLONE ORAL | 35 |
| 8 | PREDNISOLONE ORAL SOLUTION | 35 |
| 9 | FOLIC ACID | 32 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEFOTETAN | 2 | 0.0150 |
| 1 | VINBLASTINE SULFATE | 20 | 0.0102 |
| 2 | MARAVIROC | 13 | 0.0057 |
| 3 | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | 2 | 0.0050 |
| 4 | MEXILETINE HYDROCHLORIDE | 2 | 0.0048 |
| 5 | BERBERIS VULGARIS, ISATIS TINCTORIA, MORINDA CITRIFOLIA, PETIVERIA TETRANDRA, SCHINUS MOLLE, THYMOLUM, UVA-URSI | 1 | 0.0034 |
| 6 | BLEOMYCIN SULFATE | 29 | 0.0028 |
| 7 | PALIFERMIN | 1 | 0.0026 |
| 8 | BEXAROTENE | 3 | 0.0023 |
| 9 | DEXRAZOXANE FOR INJECTION | 2 | 0.0021 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 13 | 0.0057 |
| 1 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 2 | CD30-directed Immunoconjugate [EPC] | 8 | 0.0008 |
| 3 | Protease Inhibitor [EPC] | 34 | 0.0008 |
| 4 | Lipid Emulsion [EPC] | 2 | 0.0008 |
| 5 | Rifamycin Antimycobacterial [EPC] | 2 | 0.0006 |
| 6 | Cytochrome P450 3A Inhibitor [EPC] | 34 | 0.0006 |
| 7 | Sulfone [EPC] | 6 | 0.0006 |
| 8 | Interleukin-1 Receptor Antagonist [EPC] | 9 | 0.0005 |
| 9 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 11 | 0.0005 |